Cargando…
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344296/ https://www.ncbi.nlm.nih.gov/pubmed/28152544 http://dx.doi.org/10.1038/bjc.2017.18 |
_version_ | 1782513510553485312 |
---|---|
author | Patel, Girijesh Kumar Khan, Mohammad Aslam Bhardwaj, Arun Srivastava, Sanjeev K Zubair, Haseeb Patton, Mary C Singh, Seema Khushman, Moh'd Singh, Ajay P |
author_facet | Patel, Girijesh Kumar Khan, Mohammad Aslam Bhardwaj, Arun Srivastava, Sanjeev K Zubair, Haseeb Patton, Mary C Singh, Seema Khushman, Moh'd Singh, Ajay P |
author_sort | Patel, Girijesh Kumar |
collection | PubMed |
description | BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracentrifugation was performed to isolate extracellular vesicles (EVs) based on their size from vehicle- or gemcitabine-treated PC cells. Extracellular vesicles size and subtypes were determined by dynamic light scattering and marker profiling, respectively. Gene expression was examined by qRT-PCR and/or immunoblot analyses, and direct targeting of DCK by miR-155 was confirmed by dual-luciferase 3′-UTR reporter assay. Flow cytometry was performed to examine the apoptosis indices and reactive oxygen species (ROS) levels in PC cells using specific dyes. Cell viability was determined using the WST-1 assay. RESULTS: Conditioned media (CM) from gemcitabine-treated PC cells (Gem-CM) provided significant chemoprotection to subsequent gemcitabine toxicity and most of the chemoresistance conferred by Gem-CM resulted from its EVs fraction. Sub-fractionation grouped EVs into distinct subtypes based on size distribution and marker profiles, and exosome (Gem-Exo) was the only sub-fraction that imparted chemoresistance. Gene expression analyses demonstrated upregulation of SOD2 and CAT (ROS-detoxifying genes), and downregulation of DCK (gemcitabine-metabolising gene) in Gem-Exo-treated cells. SOD/CAT upregulation resulted, at least in part, from exosome-mediated transfer of their transcripts and they suppressed basal and gemcitabine-induced ROS production, and partly promoted chemoresistance. DCK downregulation occurred through exosome-delivered miR-155 and either the functional suppression of miR-155 or restoration of DCK led to marked abrogation of Gem-Exo-mediated chemoresistance. CONCLUSIONS: Together, these findings establish a novel role of exosomes in mediating the acquired chemoresistance of PC. |
format | Online Article Text |
id | pubmed-5344296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53442962018-02-28 Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK Patel, Girijesh Kumar Khan, Mohammad Aslam Bhardwaj, Arun Srivastava, Sanjeev K Zubair, Haseeb Patton, Mary C Singh, Seema Khushman, Moh'd Singh, Ajay P Br J Cancer Translational Therapeutics BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracentrifugation was performed to isolate extracellular vesicles (EVs) based on their size from vehicle- or gemcitabine-treated PC cells. Extracellular vesicles size and subtypes were determined by dynamic light scattering and marker profiling, respectively. Gene expression was examined by qRT-PCR and/or immunoblot analyses, and direct targeting of DCK by miR-155 was confirmed by dual-luciferase 3′-UTR reporter assay. Flow cytometry was performed to examine the apoptosis indices and reactive oxygen species (ROS) levels in PC cells using specific dyes. Cell viability was determined using the WST-1 assay. RESULTS: Conditioned media (CM) from gemcitabine-treated PC cells (Gem-CM) provided significant chemoprotection to subsequent gemcitabine toxicity and most of the chemoresistance conferred by Gem-CM resulted from its EVs fraction. Sub-fractionation grouped EVs into distinct subtypes based on size distribution and marker profiles, and exosome (Gem-Exo) was the only sub-fraction that imparted chemoresistance. Gene expression analyses demonstrated upregulation of SOD2 and CAT (ROS-detoxifying genes), and downregulation of DCK (gemcitabine-metabolising gene) in Gem-Exo-treated cells. SOD/CAT upregulation resulted, at least in part, from exosome-mediated transfer of their transcripts and they suppressed basal and gemcitabine-induced ROS production, and partly promoted chemoresistance. DCK downregulation occurred through exosome-delivered miR-155 and either the functional suppression of miR-155 or restoration of DCK led to marked abrogation of Gem-Exo-mediated chemoresistance. CONCLUSIONS: Together, these findings establish a novel role of exosomes in mediating the acquired chemoresistance of PC. Nature Publishing Group 2017-02-28 2017-02-02 /pmc/articles/PMC5344296/ /pubmed/28152544 http://dx.doi.org/10.1038/bjc.2017.18 Text en Copyright © 2017 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Translational Therapeutics Patel, Girijesh Kumar Khan, Mohammad Aslam Bhardwaj, Arun Srivastava, Sanjeev K Zubair, Haseeb Patton, Mary C Singh, Seema Khushman, Moh'd Singh, Ajay P Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK |
title | Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK |
title_full | Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK |
title_fullStr | Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK |
title_full_unstemmed | Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK |
title_short | Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK |
title_sort | exosomes confer chemoresistance to pancreatic cancer cells by promoting ros detoxification and mir-155-mediated suppression of key gemcitabine-metabolising enzyme, dck |
topic | Translational Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344296/ https://www.ncbi.nlm.nih.gov/pubmed/28152544 http://dx.doi.org/10.1038/bjc.2017.18 |
work_keys_str_mv | AT patelgirijeshkumar exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT khanmohammadaslam exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT bhardwajarun exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT srivastavasanjeevk exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT zubairhaseeb exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT pattonmaryc exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT singhseema exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT khushmanmohd exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck AT singhajayp exosomesconferchemoresistancetopancreaticcancercellsbypromotingrosdetoxificationandmir155mediatedsuppressionofkeygemcitabinemetabolisingenzymedck |